Your browser doesn't support javascript.
loading
Reply to the letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by S. Montenegro, C. Helwig, J.-E. Schwarze, C. Castello-Bridoux, S. Marque, M. Lispi, et al. (J Gynecol Obstet Hum Reprod. 2023;52(8):102640).
Barriere, Paul; Arbo, Elisangela; Jenkins, Julian.
Affiliation
  • Barriere P; Nantes Université, Centre Hospitalier Universitaire Nantes, CRT2I UMR A1064 Nantes, France. Electronic address: paul.barriere@chu-nantes.fr.
  • Arbo E; Medical Affairs Department, Gedeon Richter France, 103 Bd Haussmann, Paris 75008, France.
  • Jenkins J; Gedeon Richter Suisse, Route de Frontenex 41A, Geneva 1207, Switzerland.
J Gynecol Obstet Hum Reprod ; 52(8): 102644, 2023 10.
Article in En | MEDLINE | ID: mdl-37573940
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Limits: Humans Country/Region as subject: Europa Language: En Journal: J Gynecol Obstet Hum Reprod Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals Limits: Humans Country/Region as subject: Europa Language: En Journal: J Gynecol Obstet Hum Reprod Year: 2023 Document type: Article